[Management of endocrine dysfunctions after allogeneic hematopoietic stem cell transplantation: a report of the SFGM-TC on dyslipidemia and thyroid disorders]. / Suivi et prise en charge des troubles endocriniens en post-greffe de cellules souches hématopoïétiques: dyslipidémie et thyropathie.
Pathol Biol (Paris)
; 61(4): 168-70, 2013 Aug.
Article
en Fr
| MEDLINE
| ID: mdl-24011967
ABSTRACT
In the attempt to harmonize clinical practices between different French transplantation centers, the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC) set up the third annual series of workshops which brought together practitioners from all member centers and took place in October 2012 in Lille. Here we report our results and recommendations regarding the management of short and long-term endocrine dysfunction following allogeneic stem cell transplantation. The key aim of this workshop was to give an overview on dyslipidemia and thyroid disorders post-transplant.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Enfermedades de la Tiroides
/
Trasplante de Células Madre Hematopoyéticas
/
Enfermedades del Sistema Endocrino
/
Dislipidemias
Tipo de estudio:
Etiology_studies
/
Guideline
Límite:
Humans
Idioma:
Fr
Año:
2013
Tipo del documento:
Article